0001073397-20-000003.txt : 20200610
0001073397-20-000003.hdr.sgml : 20200610
20200610182405
ACCESSION NUMBER: 0001073397-20-000003
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200608
FILED AS OF DATE: 20200610
DATE AS OF CHANGE: 20200610
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LOPEZ GEORGE A
CENTRAL INDEX KEY: 0001073397
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34634
FILM NUMBER: 20955722
MAIL ADDRESS:
STREET 1: C/O ICU MEDICAL
STREET 2: 951 CALLE AMANECER
CITY: SAN CLEMENTE
STATE: CA
ZIP: 92673
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ICU MEDICAL INC/DE
CENTRAL INDEX KEY: 0000883984
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 330022692
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 951 CALLE AMANECER
CITY: SAN CLEMENTE
STATE: CA
ZIP: 92763-6212
BUSINESS PHONE: 949-366-2183
MAIL ADDRESS:
STREET 1: 951 CALLE AMANECER
CITY: SAN CLEMENTE
STATE: CA
ZIP: 92763-6212
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2020-06-08
0
0000883984
ICU MEDICAL INC/DE
ICUI
0001073397
LOPEZ GEORGE A
951 CALLE AMANECER
SAN CLEMENTE
CA
92673
1
0
1
0
Common Stock
2020-06-08
4
X
0
1200
46.53
A
340964
D
Common Stock
2020-06-08
4
S
0
1200
203.113
D
339764
D
Common Stock
2020-06-09
4
X
0
8800
46.53
A
348564
D
Common Stock
2020-06-09
4
S
0
4995
193.2944
D
343569
D
Common Stock
2020-06-09
4
S
0
505
194.5837
D
343064
D
Common Stock
2020-06-09
4
S
0
1200
196.1643
D
341864
D
Common Stock
2020-06-09
4
S
0
1100
197.1898
D
340764
D
Common Stock
2020-06-09
4
S
0
1000
198.9338
D
339764
D
Common Stock
2020-06-09
5
G
0
4950
0.0
D
334814
D
Common Stock
986843
I
by Partnership
Non-Qualified Stock Option (right to buy)
46.53
2020-06-08
4
X
0
1200
46.53
D
2022-02-01
Common Stock
1200
64095
D
Non-Qualified Stock Option (right to buy)
46.53
2020-06-09
4
X
0
8800
46.53
D
2022-02-01
Common Stock
8800
55295
D
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $203.00 to $203.27, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $192.91 to $193.52, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $194.06 to $194.93, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $195.88 to $196.80, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $197.03 to $197.44, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $198.30 to $199.10, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
This was a bona fide gift with no payment in consideration
Options vest and are exercisable as to 25% of the underlying grant one year after the date of grant and in equal monthly installments thereafter for three additional years.
By: Paula Darbyshire, Attorney-in-fact For: George A. Lopez, M.D.
2020-06-10